Pharmaceutical Product Supply – Ondansetron Hydrochloride Injection

The contract involves the supply of sterile Ondansetron Hydrochloride Injection to meet stringent quality standards set by the FDA, USP, and the Department of Defense, ensuring the product is manufactured and handled to the highest regulatory and operational specifications. This subcontract falls under NAICS code 325412, indicating pharmaceutical preparation manufacturing, and is managed by the Defense Logistics Agency under the Department of Defense with the primary objective of maintaining a consistent, secure, and compliant supply chain for military and federal healthcare systems. The product must adhere to exacting requirements for labeling, packaging, and chain of custody to guarantee integrity from production to delivery. All aspects of the supply process, including manufacturing, testing, storage, and transportation, must comply with federal and industry standards to ensure sterility, potency, and safety. The contract is tied to a specific award and delivery identification, reflecting its role in sustaining essential medical inventory for DoD operations. While the exact delivery locations are not specified, the performance and distribution network is designed to support the DoD’s global logistics needs, with full accountability and traceability maintained throughout the entire lifecycle of the product.